Procurement information - Public Health Dorset

Procurement information

Community health improvement services procurement: information and guidance

Our contracts award process is easy, simple and fair. We have worked closely with the LMC and LPC who are supportive of our approach. The price for all contracts has been agreed in advanced and is fixed.

When can I apply?

The framework opened in April 2019 and will remain open for new providers throughout the duration of the contract period (potentially as long as March 2023).

If you don’t meet all the criteria straight away, you can reapply when you do.

How do I access the framework?

To view and apply for our opportunities please visit the ProContract e-procurement portal.

Please ensure you follow the application process described in the CHIS services application walk through (ref DN382042).

The Framework will operate for one year with the option to extend for a further year up to a maximum period of 4 years.

How can I to get support?

All clarifications and questions should be raised through the ProContract e-procurement portal.

Our frequently asked questions also provide helpful information and support on this procurement and the provision of services. 

Which services are included in this procurement?

The contracts listed below are included in this procurement opportunity. Further information for the mobilisation and delivery of these services can be found by clicking on the Lot name.

Lot 1: Health checks

This is a check designed for local residents aged from 40 to 74 years old, with some exceptions. The process, as laid out in government legislation, assesses a range of health factors, including smoking status, family history of coronary heart disease, body mass index, cholesterol level, blood pressure, physical activity levels, cardiovascular risk score, and alcohol consumption.

In 2017-18, 6,241 health checks were completed by GPs with a further 1,492 conducted in pharmacies.

Lot 2: Emergency hormonal contraception (EHC)

Emergency contraception can prevent pregnancy after unprotected sex or if the contraception you have used has failed – for example, a condom has split or you have missed a pill. EHC uses chemicals that affect the release of an egg, and therefore can prevent pregnancy. 

In 2017-18, 5,620 EHC interventions were delivered.

Lot 3: Long acting reversible contraception (LARC)

LARC refers to contraceptive methods that require administration less than once per cycle or month, specifically: copper intrauterine devices; progestogen-only intrauterine systems; progestogen-only injectable contraceptives; progestogen-only subdermal implants. 

In 2017-18, there were 7,695 instances of LARC.

Lot 4: Needle exchange

Needle and syringe programmes (NSPs) supply needles and syringes for people who inject drugs. In addition, they often supply other equipment used to prepare and take drugs (for example, filters, mixing containers and sterile water). The majority of needle and syringe programmes are run by pharmacies and drug services. They may operate from fixed, mobile or outreach sites. The main aim of needle and syringe programmes is to reduce the transmission of blood-borne viruses and other infections caused by sharing injecting equipment. They also reduce the risk to the public from discarded needles by providing the opportunity for disposal of used sharps.

In 2017-18, there were 17,497 visits to pharmacies for needle exchange.

Lot 5: Supervised consumption

In some instances where an individual is prescribed medication to help treat a substance use disorder, clinical guidance recommends that the patient is observed while taking what is a potentially toxic medication, to reduce the risks to the individual concerned and the wider community. 

In 2017-18, 708 individuals were registered for supervised consumption.

Lot 6: Smoking cessation

Several treatments are available to support people looking to stop smoking, including:

  • psychosocial behaviour change support, which offers people personalised support while they go through the process of quitting
  • nicotine replacement therapy, which provides a low level of nicotine, without the tar, carbon monoxide and other poisonous chemicals present in tobacco smoke, reducing harm and reducing unpleasant withdrawal effects
  • prescribed medication (i.e. Varenicline), which reduces cravings and blocks the rewarding and reinforcing effects of smoking

In 2017-18, 841 people started a quit attempt with support from their GP, 359 people had quit at 4 weeks and 140 people had quit at 12 weeks. Through Pharmacies 2,286 people started the quit, 783 people had quit at 4 weeks and 489 people had quit at 12 weeks.

Share this page

Related Assets

Related Assets

Web Content Review